Lastest from Businesswire
Sodali & Co Appoints Andrew Benett as Chief Executive Officer
NEW YORK & LONDON & SYDNEY--(BUSINESS WIRE)--Sodali & Co (the ‘firm’ or ‘Sodali’ and formerly Morrow Sodali), a leading global advisory firm, is pleased to announce the appointment of Andrew Benett as Chief Executive Officer, effective immediately. He will be based in New York. Andrew has a 30-year career across global advisory businesses including Global CEO and Chief Strategy Officer at Havas Creative Group, Chief Commercial Officer of Bloomberg Media and CEO and Executive Chair of Harte
Cirium Ascend Consultancy Lands ‘Appraiser of the Year’ Title for the 10th Time
LONDON--(BUSINESS WIRE)--Cirium Ascend Consultancy has once again landed Airline Economics’ prestigious title of ‘Appraiser of the Year’
Parkinson Benson Potter Files Lawsuit Against Southern California Edison Company and Edison International for Role in Eaton Fire
LOS ANGELES--(BUSINESS WIRE)--San Francisco-based Parkinson Benson Potter filed a lawsuit on Monday, January 13, 2025, against Southern California Edison Company and Edison International (“Edison”) for their role in causing the devastating Eaton Fire in Southern California. The law firm represents more than 200 victims of the fire that has burned, so far, more than 14,000 acres, and destroyed about 7,000 structures. The fire is one of the largest wildfires in Los Angeles County history. Accordi
Rosen Law Firm Urges Pacira BioSciences, Inc. (NASDAQ: PCRX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of all purchasers or acquirers of securities of Pacira BioSciences, Inc. (NASDAQ: PCRX) between August 2, 2023 and August 8, 2024, both dates inclusive (the “Class Period”). Pacira is a pharmaceutical company. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating th
MobileAction Enters Strategic Partnership with Skai to Enhance Apple Search Ads Capabilities
SAN FRANCISCO--(BUSINESS WIRE)--MobileAction announced that it has expanded its commitment to the Apple Search Ads ecosystem. Skai (formerly Kenshoo) has entrusted MobileAction with the opportunity to integrate its Apple Search Ads business into MobileAction’s offering. This combination significantly expands MobileAction’s capabilities and offerings, enabling the company to support app developers and marketers through the entire lifecycle of user acquisition and growth across the Apple Search A
MAX Investors Have Opportunity to Join MediaAlpha, Inc. Securities Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)--MAX Investors Have Opportunity to Join MediaAlpha, Inc. Securities Fraud Investigation with the Schall Law Firm
MU Investors Have Opportunity to Lead Micron Technology, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)--MU Investors Have Opportunity to Lead Micron Technology, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Pacific Community Fund Launches Zero-Interest LA Fire Relief Fund Loan Program to Help Affected Residents and Essential Workers
PASADENA, Calif.--(BUSINESS WIRE)--Pacific Community Fund has launched the LA Fire Relief Fund zero-interest loan program to provide immediate financial relief to residents, small businesses, and essential workers impacted by the recent fires in the Los Angeles area. Zero-interest, $1,500 loans are available until February 10, 2025, or until funds are fully allocated. Visit pacific-fund.org/. Through collaborations with community-based nonprofits, Pacific Community Fund is working tirelessly to
Sixth Street Lending Partners Announces Extension of Exchange Offer for its 6.500% Notes due 2029 and its 5.750% Notes due 2030
NEW YORK--(BUSINESS WIRE)--Sixth Street Lending Partners (“SSLP” or the “Company”) announced today that it had extended its offer (the “Exchange Offer”) to exchange all of its outstanding (i) 6.500% Notes due 2029 that were issued in transactions not requiring registration under the Securities Act of 1933, as amended (the “1933 Act”) on March 11, 2024, and June 17, 2024 (the “6.500% Restricted Notes”) and (ii) 5.750% Notes due 2030 that were issued in a transaction not requiring registration un
XBIT Investors Have Opportunity to Join XBiotech Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)--XBIT Investors Have Opportunity to Join XBiotech Inc. Fraud Investigation with the Schall Law Firm
ENFUSION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Enfusion, Inc. - ENFN
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Enfusion, Inc. (NYSE: ENFN) to Clearwater Analytics Holdings, Inc. (NYSE: CWAN). Under the terms of the proposed transaction, shareholders of Enfusion will receive $5.85 in cash and $5.40 in Clearwater Class A Common Stock for each share of Enfusion that they own. KSF is seeking to determine whether this consi
INTRA-CELLULAR THERAPIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intra-Cellular Therapies, Inc. - ITCI
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Intra-Cellular Therapies, Inc. (NasdaqGS: ITCI) to Johnson & Johnson (NYSE: JNJ). Under the terms of the proposed transaction, shareholders of Intra-Cellular will receive $132.00 in cash for each share of Intra-Cellular that they own. KSF is seeking to determine whether this consideration and the process t
Shareholder Alert: Ademi LLP investigates whether Salarius Pharmaceuticals, Inc. is obtaining a Fair Price for its Public Shareholders
MILWAUKEE--(BUSINESS WIRE)--Ademi LLP is investigating Salarius (NASDAQ: SLRX) for possible breaches of fiduciary duty and other violations of law in its transaction with Decoy Therapeutics. Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995. There is no cost or obligation to you. In the reverse merger transaction, Salarius stockholders would own only approximately 14% of the outstanding shares and
Kirby McInerney LLP Urges Investors in Dentsply Sirona Inc. (XRAY) to Inquire About Their Rights in Class Action Lawsuit
NEW YORK--(BUSINESS WIRE)---- $XRAY #CLASSACTIONLAWSUIT--The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired Dentsply Sirona Inc. (“Dentsply” or the “Company”) (NASDAQ:XRAY) securities between May 6, 2021, through and including November 6, 2024 (“the Class Period”). Investors have until January 27, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit. [LEARN MO
Shareholder Alert: Ademi LLP investigates whether Intra-Cellular Therapies, Inc. is obtaining a Fair Price for its Public Shareholders
MILWAUKEE--(BUSINESS WIRE)--Ademi LLP is investigating Intra-Cellular Therapies (Nasdaq: ITCI) for possible breaches of fiduciary duty and other violations of law in its transaction with Johnson & Johnson. Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995. There is no cost or obligation to you. In the transaction, Intra-Cellular Therapies stockholders will receive only $132.00 per share in cash
Atlantic Union Bankshares Corporation and Sandy Spring Bancorp, Inc. Announce Receipt of Federal Reserve Approvals to Complete Mergers
RICHMOND, Va. & OLNEY, Md.--(BUSINESS WIRE)--Atlantic Union Bankshares receives approval from Federal Reserve for Sandy Spring acquistion
Rosen Law Firm Encourages TransMedics Group, Inc. Investors to Inquire About Securities Class Action Investigation – TMDX
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of TransMedics Group, Inc. (NASDAQ: TMDX) resulting from allegations that TransMedics may have issued materially misleading business information to the investing public. So What: If you purchased TransMedics securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee
Barclays Bank PLC Amends Purchase Price of Certain Cash Tender Offers and Consent Solicitations
NEW YORK--(BUSINESS WIRE)--Barclays Bank PLC (the “Issuer”) announced today that, in connection with its previously announced cash tender offers (each, an “Offer”) to purchase any and all of its outstanding exchange-traded notes (the “Notes” or the “ETNs”) of four separate series (each, a “Series”) and the solicitation of consents (each, a “Consent Solicitation”) from holders of the Notes (the “Noteholders”) to amend certain provisions of the Notes with respect to each Series, it has amended th
ENFN Investors Have the Opportunity to Join Investigation of Enfusion, Inc. With the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)--ENFN Investors Have the Opportunity to Join Investigation of Enfusion, Inc. with the Schall Law Firm
KBRA Assigns Rating to Blue Owl Technology Finance Corp.'s Senior Unsecured Notes
NEW YORK--(BUSINESS WIRE)-- #creditratingagency--KBRA assigns a rating of BBB to Blue Owl Technology Finance Corp. ("OTF" or "the company") $650 million, 6.100% senior unsecured notes due March 15, 2028. The rating Outlook is Stable. Key Credit Considerations OTF benefits from its ties to the $128.4 billion Blue Owl Credit platform, with approximately $27 billion deployed into the technology strategy across all funds since inception. The experienced management team that has decades of experience working in the priva